These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34353431)
1. Emerging roles of PHLPP phosphatases in metabolism. Cha JH; Jeong Y; Oh AR; Lee SB; Hong SS; Kim K BMB Rep; 2021 Sep; 54(9):451-457. PubMed ID: 34353431 [TBL] [Abstract][Full Text] [Related]
2. PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases. Hribal ML; Mancuso E; Spiga R; Mannino GC; Fiorentino TV; Andreozzi F; Sesti G Expert Opin Ther Targets; 2016 Jun; 20(6):663-75. PubMed ID: 26652182 [TBL] [Abstract][Full Text] [Related]
3. PHLPPs: Emerging players in metabolic disorders. Balamurugan K; Chandra K; Sai Latha S; Swathi M; Joshi MB; Misra P; Parsa KVL Drug Discov Today; 2022 Oct; 27(10):103317. PubMed ID: 35835313 [TBL] [Abstract][Full Text] [Related]
4. PHLPP: a putative cellular target during insulin resistance and type 2 diabetes. Mathur A; Pandey VK; Kakkar P J Endocrinol; 2017 Jun; 233(3):R185-R198. PubMed ID: 28428363 [TBL] [Abstract][Full Text] [Related]
5. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling. Baffi TR; Cohen-Katsenelson K; Newton AC Annu Rev Pharmacol Toxicol; 2021 Jan; 61():723-743. PubMed ID: 32997603 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. Lupse B; Annamalai K; Ibrahim H; Kaur S; Geravandi S; Sarma B; Pal A; Awal S; Joshi A; Rafizadeh S; Madduri MK; Khazaei M; Liu H; Yuan T; He W; Gorrepati KDD; Azizi Z; Qi Q; Ye K; Oberholzer J; Maedler K; Ardestani A Cell Rep; 2021 Aug; 36(5):109490. PubMed ID: 34348155 [TBL] [Abstract][Full Text] [Related]
7. Emerging roles of PHLPP phosphatases in lung cancer. Xia X; Pi W; Chen M; Wang W; Cai D; Wang X; Lan Y; Yang H Front Oncol; 2023; 13():1216131. PubMed ID: 37576883 [TBL] [Abstract][Full Text] [Related]
8. Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. Qiao M; Wang Y; Xu X; Lu J; Dong Y; Tao W; Stein J; Stein GS; Iglehart JD; Shi Q; Pardee AB Mol Cell; 2010 May; 38(4):512-23. PubMed ID: 20513427 [TBL] [Abstract][Full Text] [Related]
9. Suppression of survival signalling pathways by the phosphatase PHLPP. O'Neill AK; Niederst MJ; Newton AC FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730 [TBL] [Abstract][Full Text] [Related]
10. Emerging roles of PHLPP phosphatases in the nervous system. Mallick A; Sharma M; Dey CS Mol Cell Neurosci; 2022 Dec; 123():103789. PubMed ID: 36343848 [TBL] [Abstract][Full Text] [Related]
11. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
12. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL. Rajala RV; Kanan Y; Anderson RE Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440 [TBL] [Abstract][Full Text] [Related]
13. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms. Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608 [TBL] [Abstract][Full Text] [Related]
14. PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus. Jackson TC; Verrier JD; Semple-Rowland S; Kumar A; Foster TC J Neurochem; 2010 Nov; 115(4):941-55. PubMed ID: 20819118 [TBL] [Abstract][Full Text] [Related]
15. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling. Warfel NA; Newton AC J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674 [TBL] [Abstract][Full Text] [Related]
16. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637 [TBL] [Abstract][Full Text] [Related]
17. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer. Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623 [TBL] [Abstract][Full Text] [Related]
18. Turning off AKT: PHLPP as a drug target. Newton AC; Trotman LC Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697 [TBL] [Abstract][Full Text] [Related]
19. Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output. Reyes G; Niederst M; Cohen-Katsenelson K; Stender JD; Kunkel MT; Chen M; Brognard J; Sierecki E; Gao T; Nowak DG; Trotman LC; Glass CK; Newton AC Proc Natl Acad Sci U S A; 2014 Sep; 111(38):E3957-65. PubMed ID: 25201979 [TBL] [Abstract][Full Text] [Related]
20. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway. Ishibashi O; Akagi I; Ogawa Y; Inui T Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]